CDMO Services - API
Product Description
Genovior Biotech Corporation
-
TW -
2016On CPHI since
-
1Certificates
-
100 - 249Employees
Company types
Primary activities
Categories
Specifications
Genovior Biotech Corporation
-
TW
-
2016On CPHI since
-
1Certificates
-
100 - 249Employees
Company types
Primary activities
More Products from Genovior Biotech Corporation (7)
-
Product Semaglutide (GLP-1 Drug)
API < USD 500 per gram, COA available Finished product -
Product CDMO Services
Genovior is a dedicated CMO/CDMO, focusing on providing clients excellent, efficient, one stop services and solutions, from clinical trials (IND/NDA) to commercialization.
Our services include:
1. Process Development
2. Formulation Development
3. Analytical Development
... -
Product CDMO Services - FDF drugs
VialsPrefilled Syringe
Injection Pen -
Product Genovior Products - API
• Azacitidine (Oncology) • Bortezomib (Oncology) • Fulvestrant (Oncology) • Pemetrexed (Oncology) • Ponatinib (Oncology) • Glucagon (Endocrinology) • Octreotide (Endocrinology) • Teriparatide (Osteoporosis)
-
Product Genovior Products - FDF Drugs List 1
Azacitidine inj
Bortezomib inj
Docetaxel inj
Doxorubicin inj
Epirubicin inj
Fulvestrant inj
Gemcitabine inj
... -
Product Genovior Products - FDF Drugs List 2
Acyclovir inj
Colistin inj
Ganciclovir inj
Teicoplanin inj
Vancomycin inj
Levetiracetam inj
Valproate inj
... -
Product Interview by Newsweek, time to talk
Interviewee：Dr. Steve J.P. Hsu (President of Genovior Biotech)
Genovior Biotech Corporation resources (5)
-
Video COMPANY PRESENTATION
Genovior is a dedicated CMO/CDMO, focusing on providing clients excellent, efficient, one stop services and solutions, from clinical trials (IND/NDA) to commercialization.
Our services include:
1. Process Development
2. Formulation Development
3. Analytical Development
4. Small Scale Biologics / Injectable Production
5. Commercial Scale Injectable Production
6. Dedicated Oncology Production (API / Injectables)
7. Regulatory Affairs
Generic/Peptide/Biosimilar projects available for out-licensing
Oncology-Azacitidine, Bortezomib, Pemetrexed, Fulvestrant
Peptide-Glucagon, Teriparatide, Octreotide, Terlipressin
Biosimilar-Liraglutide, Ranibizumab, Denosumab
Others-Levetiracetam, Palonosetron, Valproate
-
Brochure Interview by Newsweek, Time to Talk
Interviewee：Dr. Steve J. P. Hsu (President of Genovior Biotech)
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance